12ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
  • Program
    • Schedule
    • 22.10.2022
    • 23.10.2022
    • 24.10.2022
    • Scientific Committee
  • Media
    • Photos
    • Videos
    • Downloads
    • Abstracts
  • Newsletters
  • Acknowledgements
  • Sponsors
  • Other Archives
    • ISHL13
    • ISHL12
    • Update on Hodgkin Lymphoma
    • ISHL11
    • ISHL10
    • ISHL9
    • ISHL8
    • ISHL7
Back to video list

Discussion forum: Challenging standard recommendations from a patient's, nurse's and physician's perspective

Speaker

Martin Dreyling, Sarah Wells, Jack Richardson

Session

Advanced Stages

Others Talks of this Session

  • Why I recommend BV-AVD
  • Why I recommend PET-guided ABVD
  • Why I recommend PET-adapted escalated BEACOPP
  • WS Report: Learning through International Collaboration
  • FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial
  • Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group

Quicklink

  1. Program
  2. General
  3. Sponsors
  4. Contact
  5. Partners
  1. Abstracts
  2. Downloads
  3. Legal Info
  4. Archive
  5. Privacy Policy

How to contact us

German Hodgkin Study Group (GHSG)
University Hospital of Cologne

Kerpener Str. 62
D-50924 Köln

info@hodgkinsymposium.org

This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies. Learn more